A pharmacoeconomic assessment of recombinant tissue plasminogen activator therapy for acute ischemic stroke in a tertiary hospital in China.

@article{Yan2015APA,
  title={A pharmacoeconomic assessment of recombinant tissue plasminogen activator therapy for acute ischemic stroke in a tertiary hospital in China.},
  author={Xin Yan and Hong-tao Hu and Sizhu Liu and Yu-heng Sun and Xin Gao},
  journal={Neurological research},
  year={2015},
  volume={37 4},
  pages={352-8}
}
OBJECTIVES To conduct a pharmacoeconomic assessment of thrombolysis by intravenous recombinant tissue plasminogen activator (rt-PA) therapy for acute ischemic stroke (AIS) in 6 hours in a tertiary hospital in China. MATERIALS AND METHODS A retrospective analysis was conducted using medical records data among patients hospitalized for AIS and receiving treatment with or without rt-PA (6 hours after AIS) from January 2006 to December 2008. The conservative therapy group was matched (1∶1) on age… CONTINUE READING